This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Rite Aid Stock Falls on FY19 View Cut Ahead of Merger Vote
by Zacks Equity Research
Rite Aid (RAD) lowers fiscal 2019 guidance as the generic drug purchasing efficiencies fall below expectations. Rite Aid shareholders are likely to vote for the Albertsons merger on Aug 9.
Why Amazon (AMZN) Stock Is A Strong Buy Right Now
by Benjamin Rains
Nearly everyone knows that Amazon (AMZN) stock has been one of the hottest on Wall Street for years. Yet some assume now is too late to get in on the fun, which simply isn't true. So let's take a look at why investors should buy Amazon stock right now following yet another quarter of stellar growth.
Why Apple Pay, AirPods, & Services Are More Vital Than Ever
by Benjamin Rains
Apple (AAPL) saw its stock price climb Wednesday as it inches ever closer to that elusive $1 trillion market cap. The firm's iPhone revenues surged once again during its fiscal Q3, but investors seem much more excited about Apple's growing Services unit, which features Apple Music, Apple Pay, along with other newer businesses.
Apple Earnings Preview, Chipotle Woes, News from NAKD, CVS, SHOP | Free Lunch
by Ryan McQueeney
Ryan McQueeney discusses Chipotle's latest foodborne illness trouble, the new partnership between Naked Brands and CVS, and Shopify's earnings report. Later, he is joined by Zacks Strategist Brian Bolan to preview the upcoming earnings announcement of tech behemoth Apple.
Is CVS Health (CVS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in the Cards for CVS Health (CVS) in Q2 Earnings?
by Zacks Equity Research
CVS Health (CVS) is optimistic about living up to its strong earnings surprise history year over year in Q2 as well, courtesy of gains from the Pharmacy Services segment.
5 Low Price-to-Book Stocks That Can Prove to be Valuable
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
One of Wall Street's Top Analysts Warns Against Trade War
by Chloe Shin
With the trade war looming upon us, Goldman Sachs chief U.S. equity strategist David Kostin warned investors about how it will affect U.S. Companies. According to Kostin, if trade tensions worsen, and a 10 percent tariff were imposed on all U.S. imports, Goldman would lower its 2019 S&P 500 EPS estimate by 15 percent.
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
by Zacks Equity Research
Zacks.com featured highlights include: ConocoPhillips, Archer Daniels, CVS, Fortinet and Avnet
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS, RH, Groupon, Darden and Carrols